Molly Finger, APRN
Family · Lakeland, FLNPI 1194375485
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,400 of the $10,478 with a category attached, or 80.2%. Deciphera Pharmaceuticals Inc. accounts for 96.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $5,124 and has fallen 96.9% since, to $160 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $388.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Deciphera Pharmaceuticals Inc.$10K
- Amgen$139
- Merck$90
- Novocure Inc.$62
- Baxter Healthcare$39
- Novo Nordisk$33
- plus $41 from 2 others
What the payments were for
- Speaking & faculty fees$8,40080%
- Travel & lodging$1,62015%
- Food & beverage$4584%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 17 | $10,073 |
| Amgen | 2 | $139 |
| Merck | 1 | $90 |
| Novocure Inc. | 2 | $62 |
| Baxter Healthcare | 1 | $39 |
| Novo Nordisk | 2 | $33 |
| Genentech USA, Inc. | 1 | $21 |
| AbbVie | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,478 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 11 | $167 |
Paid to pharmacies, not to this prescriber.
Other family in Lakeland
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.